- Home
- GHI vs IRWD Comparison
GHI vs IRWD Comparison
Compare GHI & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHI
- IRWD
- Stock Information
- Founded
- GHI 1998
- IRWD 1998
- Country
- GHI United States
- IRWD United States
- Employees
- GHI N/A
- IRWD N/A
- Industry
- GHI Finance: Consumer Services
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- GHI Finance
- IRWD Health Care
- Exchange
- GHI Nasdaq
- IRWD Nasdaq
- Market Cap
- GHI 254.1M
- IRWD 251.8M
- IPO Year
- GHI N/A
- IRWD 2010
- Fundamental
- Price
- GHI $8.30
- IRWD $1.87
- Analyst Decision
- GHI Strong Buy
- IRWD Buy
- Analyst Count
- GHI 4
- IRWD 5
- Target Price
- GHI $14.88
- IRWD $4.94
- AVG Volume (30 Days)
- GHI 123.5K
- IRWD 1.2M
- Earning Date
- GHI 11-06-2025
- IRWD 11-04-2025
- Dividend Yield
- GHI 17.90%
- IRWD N/A
- EPS Growth
- GHI N/A
- IRWD N/A
- EPS
- GHI N/A
- IRWD N/A
- Revenue
- GHI $27,326,828.00
- IRWD $308,519,000.00
- Revenue This Year
- GHI $223.15
- IRWD N/A
- Revenue Next Year
- GHI $5.11
- IRWD N/A
- P/E Ratio
- GHI N/A
- IRWD N/A
- Revenue Growth
- GHI N/A
- IRWD N/A
- 52 Week Low
- GHI $8.20
- IRWD $0.53
- 52 Week High
- GHI $13.29
- IRWD $5.13
- Technical
- Relative Strength Index (RSI)
- GHI 15.88
- IRWD 64.07
- Support Level
- GHI $8.20
- IRWD $1.47
- Resistance Level
- GHI $8.72
- IRWD $1.65
- Average True Range (ATR)
- GHI 0.27
- IRWD 0.15
- MACD
- GHI -0.07
- IRWD 0.02
- Stochastic Oscillator
- GHI 5.26
- IRWD 64.93
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.